AI assistant
Sending…
Sopharma AD — Earnings Release 2019
Jun 5, 2019
2543_rns_2019-06-05_28512548-1371-49dc-b655-dfa3c8a552af.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report No. 15 / 2019 Dated June 5, 2019
NOTIFICATION
Sopharma AD (the "Company") notifies that for May 2019 the Company recorded an increase in sales of 22% compared to the same month of 2018, incl. 1% increase in sales for the domestic market and 36% growth in export sales.
In the first five months of 2019 the revenues from sales of production increased by 1% compared to the same period of 2018, incl. 13% decrease in domestic sales and 11% increase of export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19